Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


2 Allergy
2 Am J Respir Cell Mol Biol
3 Am J Respir Crit Care Med
2 Ann Allergy Asthma Immunol
1 BMC Pediatr
2 Clin Exp Allergy
3 Int Arch Allergy Immunol
1 J Allergy Clin Immunol
9 J Asthma
3 Pediatr Pulmonol
1 PLoS One
1 Respir Med
2 Respir Res
4 Thorax

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. CARUSO C, Colantuono S, Ciasca G, Basile U, et al
    Different aspects of severe asthma in real life: role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity.
    Allergy. 2022 Aug 3. doi: 10.1111/all.15466.
    PubMed         Abstract available

  2. MUMBY S, Kermani NZ, Garnett JP, Pavlidis S, et al
    CEACAM5 is an IL-13-regulated epithelial gene that mediates transcription in type-2 (T2) high severe asthma.
    Allergy. 2022 Aug 2. doi: 10.1111/all.15465.

    Am J Respir Cell Mol Biol

  3. FENG Y, Chen S, Xiong L, Chang C, et al
    Cadherin-26 Amplifies Airway Epithelial IL-4 Receptor Signaling in Asthma.
    Am J Respir Cell Mol Biol. 2022 Aug 5. doi: 10.1165/rcmb.2021-0109.
    PubMed         Abstract available

  4. KOZIK AJ, Holguin F, Segal LN, Chatila TA, et al
    Microbiome, Metabolism, and Immunoregulation of Asthma: An American Thoracic Society and National Institute of Allergy and Infectious Diseases Workshop Report.
    Am J Respir Cell Mol Biol. 2022;67:155-163.
    PubMed         Abstract available

    Am J Respir Crit Care Med

  5. SILLE FCM, McCormack M, Hartung T
    The Exposome Applied: A Step Toward Defining the Totality of Environmental Exposures in Asthma.
    Am J Respir Crit Care Med. 2022 Aug 4. doi: 10.1164/rccm.202207-1430.

  6. GUTOR SS, Richmond BW, Du RH, Wu P, et al
    Characterization of Immunopathology and Small Airway Remodeling in Constrictive Bronchiolitis.
    Am J Respir Crit Care Med. 2022;206:260-270.
    PubMed         Abstract available

  7. COLAK Y, Nordestgaard BG, Lange P, Vestbo J, et al
    Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials.
    Am J Respir Crit Care Med. 2022;206:271-280.
    PubMed         Abstract available

    Ann Allergy Asthma Immunol

  8. BRYANT N, Muehling LM
    T-cell responses in asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jul 30. pii: S1081-1206(22)00621.
    PubMed         Abstract available

  9. IMAM SF, Zafar S, Oppenheimer J
    SMART in treatment of asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jul 29. pii: S1081-1206(22)00619.
    PubMed         Abstract available

    BMC Pediatr

  10. DASTOORPOOR M, Khodadadi N, Madadizadeh F, Raji H, et al
    Assessing the prevalence and severity of asthma, rhinitis, and eczema among schoolchildren (6-7 and 13-14 years old) in Khuzestan, Iran: a cross-sectional survey.
    BMC Pediatr. 2022;22:463.
    PubMed         Abstract available

    Clin Exp Allergy

  11. MILLER M, Pham AK, Gonen A, Navia-Pelaez JM, et al
    Reduced AIBP expression in bronchial epithelial cells of asthmatic patients: Potential therapeutic target.
    Clin Exp Allergy. 2022 Apr 23. doi: 10.1111/cea.14150.

  12. CHAKRABORTY S, Hammar KS, Filiou AE, Holmdahl I, et al
    Longitudinal Eosinophil-derived neurotoxin measurements and asthma development in preschool wheezers.
    Clin Exp Allergy. 2022 Jul 30. doi: 10.1111/cea.14210.

    Int Arch Allergy Immunol

  13. ARSLAN B, Pacaci Cetin G, Turk M, Gulmez I, et al
    Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?
    Int Arch Allergy Immunol. 2022 Aug 2:1-7. doi: 10.1159/000525723.
    PubMed         Abstract available

  14. LOPEZ-RODRIGUEZ R, Rial MJ, Esteban-Gorgojo I, Veleiro Perez B, et al
    Serodominance Profile in a Dust Mite Complex Region.
    Int Arch Allergy Immunol. 2022;183:843-851.
    PubMed         Abstract available

  15. HAN J, Wang W, Zhu Z, Wang L, et al
    Profile of Tissue Immunoglobulin E in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps.
    Int Arch Allergy Immunol. 2022;183:835-842.
    PubMed         Abstract available

    J Allergy Clin Immunol

  16. PHIPPS S, Howard DR, Werder RB
    Eosinophils apply a handbrake to plasmacytoid dendritic cell antiviral immunity in asthma.
    J Allergy Clin Immunol. 2022 Jul 30. pii: S0091-6749(22)00986.

    J Asthma

  17. VENKITAKRISHNAN R, Cleetus M, Augustine J, Ramachandran D, et al
    Acceptance and results of therapy with omalizumab in real world Kerala setting: reports from the ARTWORK study, Kerala, South India.
    J Asthma. 2022;59:1831-1838.
    PubMed         Abstract available

  18. PRAPAMONTOL T, Norback D, Thongjan N, Suwannarin N, et al
    Fractional exhaled nitric oxide (FeNO) in students in Northern Thailand: associations with respiratory symptoms, diagnosed allergy and the home environment.
    J Asthma. 2021 Aug 26:1-9. doi: 10.1080/02770903.2021.1968424.
    PubMed         Abstract available

  19. BATMAZ SB, Birinci G, Akpinar Aslan E
    Quality of Life of Children with Allergic Disease: The effect of Depression and Anxiety of Children and Their Mothers.
    J Asthma. 2021 Sep 9:1-17. doi: 10.1080/02770903.2021.1978480.
    PubMed         Abstract available

  20. LUGOGO NL, Bogart M, Corbridge T, Packnett ER, et al
    Impact of mepolizumab in patients with high-burden severe asthma within a managed care population.
    J Asthma. 2022 Jul 19:1-16. doi: 10.1080/02770903.2022.2102036.
    PubMed         Abstract available

  21. AGU KM, Eze JN, Muoneke UV, Uwaezuoke SN, et al
    Prevalence and determinants of psychosocial disorders in children and adolescents with asthma in Enugu, Nigeria: a comparative cross-sectional study.
    J Asthma. 2022 Aug 1:1-22. doi: 10.1080/02770903.2022.2109164.
    PubMed         Abstract available

  22. BACCELLI A, Kocwin M, Parazzini EM, Rinaldo RF, et al
    Long-Term Outcomes of Combination Biologic Therapy in Uncontrolled Severe Asthma: A Case Study.
    J Asthma. 2022 Aug 1:1-6. doi: 10.1080/02770903.2022.2109162.
    PubMed         Abstract available

  23. MATTISON N, Rookwood AC, Quintero SA, Tak HJ, et al
    Effectiveness of a community-driven, asthma intervention: Project Asthma In-Home Response.
    J Asthma. 2022 Aug 1:1-8. doi: 10.1080/02770903.2022.2109167.
    PubMed         Abstract available

  24. ANTONIO BUENDIA J, Rodriguez-Martinez CE, Sossa-Briceno MP
    Cost utility of Vitamin D supplementation in adults with mild to moderate asthma.
    J Asthma. 2022 Aug 3:1-13. doi: 10.1080/02770903.2022.2110113.
    PubMed         Abstract available

  25. SATAR S, Sahin ME, Ergun P
    Factors Affecting the Success of Pulmonary Rehabilitation in Asthma.
    J Asthma. 2022 Aug 5:1-12. doi: 10.1080/02770903.2022.2109163.
    PubMed         Abstract available

    Pediatr Pulmonol

  26. BERGER DO, Pedersen ESL, Mallet MC, de Jong CCM, et al
    External Validation of the Predicting Asthma Risk in Children (PARC) tool in a clinical cohort.
    Pediatr Pulmonol. 2022 Aug 5. doi: 10.1002/ppul.26088.
    PubMed         Abstract available

  27. CHEN IL, Chung HW, Hsieh HM, Chen SC, et al
    The prenatal and postnatal effects of air pollution on asthma in children with atopic dermatitis.
    Pediatr Pulmonol. 2022 Aug 4. doi: 10.1002/ppul.26089.
    PubMed         Abstract available

  28. KHAN S, Ouaalaya EH, Chamberlain JD, Dufourg MN, et al
    The external validation of the asthma prediction tool in the French ELFE cohort.
    Pediatr Pulmonol. 2022 Aug 4. doi: 10.1002/ppul.26085.
    PubMed         Abstract available

    PLoS One

  29. GUO YG, Zhang Y, Liu WL
    The causal relationship between allergic diseases and heart failure: Evidence from Mendelian randomization study.
    PLoS One. 2022;17:e0271985.
    PubMed         Abstract available

    Respir Med

  30. LI M, Wen Ma Z, Jun Deng S, Oliver BG, et al
    Development and validation of a noninvasive prediction model for identifying eosinophilic asthma.
    Respir Med. 2022;201:106935.
    PubMed         Abstract available

    Respir Res

  31. BODUM KS, Hjerrild BE, Dalsgaard S, Rubak SLM, et al
    Behavioural side effects of inhaled corticosteroids among children and adolescents with asthma.
    Respir Res. 2022;23:192.
    PubMed         Abstract available

  32. KAN M, Sun M, Jiang X, Diwadkar AR, et al
    CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids.
    Respir Res. 2022;23:193.
    PubMed         Abstract available


  33. SOREMEKUN S, Heaney LG, Skinner D, Bulathsinhala L, et al
    Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study.
    Thorax. 2022 Aug 3. pii: thorax-2021-217032. doi: 10.1136/thorax-2021-217032.
    PubMed         Abstract available

  34. CRUMP C, Sundquist J, Sundquist K
    Preterm or early term birth and long-term risk of asthma into midadulthood: a national cohort and cosibling study.
    Thorax. 2022 Jul 30. pii: thorax-2022-218931. doi: 10.1136/thorax-2022-218931.
    PubMed         Abstract available

  35. FUJIOGI M, Zhu Z, Raita Y, Ooka T, et al
    Nasopharyngeal lipidomic endotypes of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Thorax. 2022 Jul 30. pii: thorax-2022-219016. doi: 10.1136/thorax-2022-219016.
    PubMed         Abstract available

  36. KEARNS N, Williams M, Bruce P, Black M, et al
    Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trial.
    Thorax. 2022 Jul 18. pii: thorax-2022-219052. doi: 10.1136/thorax-2022-219052.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.